News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Agnico Eagle Mines stock has delivered a very large 3 year return, while current valuation checks suggest it is closer to fairly valued …
Sharemaestro market context Price below Trend Line 52 weeks +21.1% · Next-week setup negative 34.7%Agnico Eagle Mines Limited AEM delivered better-than-expected earnings in the second quarter on higher realized gold prices, but it remains mired in headwinds from higher costs. Its all-in sustaining costs (AISC) — the most important cost metric of miners — were $1,459 per ounce …
Sharemaestro market context Price below Trend Line 52 weeks +21.1% · Next-week setup negative 34.7%Magnite is experiencing accelerated growth in connected television (CTV) advertising, with a 36% increase in its latest quarter, driven by expanded demand from sports advertisers and small to medium-sized businesses. The company projects a 13-14% growth outlook and over 40% free-cash-flow growth for the …
Insight Molecular Diagnostics Inc (IMDX) is considered 284.7% overvalued based on its GF Value™ despite optimism around future FDA authorization for its GraftAssureDx test and expanded Medicare reimbursement. The company reported a Q2 adjusted EBITDA loss and an upward revision of its cash burn …
Earnings Call Insights: Insight Molecular Diagnostics (IMDX) Q2 2026 MANAGEMENT VIEW * "It feels great to be coming to you today with line of sight on expected FDA marketing authorization for GraftAssureDx" (President, CEO & Director Joshua Riggs), adding, "We continue to target receipt …
Magnolia Oil & Gas (NYSE:MGY) recently reported strong second-quarter results, surpassing revenue and EPS expectations. Despite this, analysts have not significantly altered their forecasts for 2026, maintaining revenue estimates at US$1.92 billion and EPS at US$2.92, with the consensus price target remaining largely unchanged …
Jane Street Group, LLC and its subsidiaries, Jane Street Capital, LLC and Jane Street Global Trading, LLC, have disclosed a 1.7% equity stake in Co-Diagnostics, Inc. (NASDAQ: CODX). This ownership amounts to 89,240 shares of common stock, held with shared voting and dispositive power. …
Lucid Diagnostics Inc is anticipated to report a loss of 7 cents per share in its upcoming earnings announcement. This preview indicates the company's expected financial performance for the period.
* Insight Molecular Diagnostics Inc. (IMDX [https://seekingalpha.com/symbol/IMDX]) is scheduled to announce Q2 earnings results on Monday, August 10th, after market close. * The consensus EPS estimate is -$0.25, [https://seekingalpha.com/symbol/IMDX/earnings/estimates] and the consensus revenue estimate is $0.44M * Over the last year, IMDX has beaten …
Insight Molecular Diagnostics (NASDAQ: IMDX) reported second-quarter EPS of $-0.230, exceeding analyst estimates of $-0.240. However, the company's revenue of $240K fell short of the consensus estimate of $470.85K. Despite the revenue miss, the company's stock price has shown significant volatility, being down -25.700% …
The provided content is not an article but rather a privacy notice or a placeholder. It does not contain any information about Insight Molecular Diagnostics or its Q2 earnings. Therefore, no meaningful summary can be generated.
Sharemaestro market context Trend signal active 52 weeks +31.8% · Next-week setup positive 58.1%This article announces the filing of a Form 8K by Insight Molecular Diagnostics Inc. on August 10. The filing is a standard regulatory announcement, and the article provides no further details beyond the company name and filing date. It appears to be a placeholder …
MAGNACHIP SEMICONDUCTOR Corp reported Q2 2026 results with revenue of $44.7M, a decrease from $47.62M in Q2 2025, and a net loss of $(4.82)M, resulting in a diluted EPS of $(0.13) compared to net income in the prior year. The decline was attributed to …
Insight Molecular Diagnostics (IMDX) reported a steep revenue drop in Q2 2026, with net revenue down sharply to $239,000 from $518,000 in the prior year, and a net loss of $11.3 million. Despite the revenue decline and increased operating expenses, the company bolstered its …
Insight Molecular Diagnostics Inc. (IMDX) reported its Q2 2026 results and provided an update on the FDA review of its GraftAssureDx product. The company is progressing with the FDA, expecting marketing authorization soon, and highlighted favorable Medicare reimbursement policy changes. IMDX also shared clinical …
JPMorgan Chase & Co. has increased its price target for Magna International (NYSE:MGA) to $77 from $70, maintaining an "overweight" rating and suggesting a 9.85% upside. This follows Magna's strong quarterly earnings report, which surpassed analyst estimates for both EPS and revenue. Despite mixed …
This article examines Magnolia Oil & Gas's Q2 production gains, focusing on its South Texas acreage, the WildFire transaction, and operating developments. It highlights the company's principal assets in the Karnes and Giddings areas, targeting the Eagle Ford Shale and Austin Chalk formations, and …
Agnico Eagle Mines Limited's AEM shares have rallied 24.6% in the past month, thanks to a rebound in gold prices and the company's forecast-topping earnings performance in the second quarter driven by higher realized prices. AEM saw 35% and 57% year-over-year growth in its …
Sharemaestro market context Price above Trend Line 52 weeks +37.3% · Next-week setup positive 59.4%JP Morgan has increased its target price for Magna International Inc. (MGA.N) to $77 from $70. This update indicates an improved outlook from the financial institution for the automotive supplier. The report was issued by Reuters.
This article first appeared on GuruFocus. Assessing the Upcoming Payout and Long-Term Sustainability Magnolia Oil & Gas Corp (NYSE:MGY) has recently declared a total dividend of $0.18 per share, with the ex-dividend date set for 2026-08-10. This upcoming payment, which includes a $0.18 per …
This article provides an overview of Insight Molecular Diagnostics Inc. (IMDX) stock, including its current price, market capitalization, key financial stats, and performance over various periods. It also highlights analyst opinions, future earnings expectations, and company details, noting the FDA review for GraftAssureDx and …
Insight Molecular Diagnostics (NASDAQ: IMDX) reported second-quarter EPS of $-0.230, exceeding analyst estimates of $-0.240. However, the company's revenue of $240K fell short of the consensus estimate of $470.85K. Despite the revenue miss, the company's stock price has shown significant volatility, being down -25.700% …
Search by ticker symbol or company name and select a result to open its chart.